These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7597381)

  • 1. Anticentromere antibody--clinical associations. A study of 44 patients.
    Caramaschi P; Biasi D; Manzo T; Carletto A; Poli F; Bambara LM
    Rheumatol Int; 1995; 14(6):253-5. PubMed ID: 7597381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere antibodies (ACA): clinical distribution and disease specificity.
    Chan HL; Lee YS; Hong HS; Kuo TT
    Clin Exp Dermatol; 1994 Jul; 19(4):298-302. PubMed ID: 7955469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.
    Bournia VK; Diamanti KD; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Res Ther; 2010; 12(2):R47. PubMed ID: 20302639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-centromere antibodies. Study of 67 positive sera].
    Renier G; Le Normand I; Chevailler A; Verret JL; Renier JC; Hurez D
    Rev Med Interne; 1992 Nov; 13(6):413-4, 417-8. PubMed ID: 1344922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
    Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.
    Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-centromere antibodies as a marker of Raynaud's phenomenon in pediatric rheumatologic diseases.
    Hossny E; Hady HA; Mabrouk R
    Pediatr Allergy Immunol; 2000 Nov; 11(4):250-5. PubMed ID: 11110581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlation of anticentromere antibodies.
    Zuber M; Gotzen R; Filler I
    Clin Rheumatol; 1994 Sep; 13(3):427-32. PubMed ID: 7835004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population.
    Catoggio LJ; Skinner RP; Maddison PJ
    Rheumatol Int; 1983; 3(1):19-21. PubMed ID: 6412349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.